SCHEMBL28511352

SCHEMBL28511352

COc1cc(Br)cc(OC)c1N1CCNCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.53
CHRNA4 P43681 1/20 0.53
ADRB1 P08588 4/20 0.49
HTR6 P50406 4/20 0.49
HTR3E A5X5Y0 3/20 0.49
HTR3B O95264 3/20 0.49
HTR3A P46098 3/20 0.49
HTR3D Q70Z44 3/20 0.49
HTR3C Q8WXA8 3/20 0.49
SIGMAR1 Q99720 2/20 0.49
DRD2 P14416 1/20 0.49
CYP2C19 P33261 1/20 0.49
DRD3 P35462 1/20 0.49
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
HTR7 P34969 2/20 0.44
HTR1A P08908 1/20 0.44
HTR2C P28335 1/20 0.44
HTR2B P41595 1/20 0.44
NCF1 P14598 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5240485 0.83 KDM4E (0.46) LMNAMAPT
SCHEMBL28513873 0.80 GAA (0.51) HTR6DRD2CYP2C19DRD3MAPT
SCHEMBL4190135 0.78 HTR6 (0.61) CHRNB2CHRNA4ADRB1HTR6HTR3E
SCHEMBL4849552 0.78 HTR3A (0.66) ADRB1HTR6HTR3EHTR3BHTR3A
SCHEMBL28905291 0.76 ADRB1 (0.47) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL14009665 0.75 HTR3E (0.68) ADRB1HTR6HTR3EHTR3BHTR3A
SCHEMBL14922246 0.75 ADRB1 (0.45) CHRNB2CHRNA4ADRB1HTR6HTR3E
SCHEMBL19869933 0.75 CYP1A2 (0.50) CHRNB2CHRNA4ADRB1
SCHEMBL8250752 0.73 ADRB1 (0.54) CHRNB2CHRNA4ADRB1HTR6HTR3E
SCHEMBL23798860 0.72 PKM (0.50) CHRNB2CHRNA4SIGMAR1LMNAHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112243439-A Pyrrolo [2,3-B ] pyridines or pyrrolo [2,3-B ] pyrazines as HPK1 inhibitors and uses thereof 百济神州有限公司 2021-01-19 CN disclosed